Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Astera Labs (ALAB) EBITDA Margin (2023 - 2026)

Astera Labs has reported EBITDA Margin over the past 3 years, most recently at 16.7% for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA Margin rose 203.0% year-over-year to 16.7%, compared with a TTM value of 26.16% through Dec 2025, up 4717.0%, and an annual FY2025 reading of 26.16%, up 4717.0% over the prior year.
  • EBITDA Margin came in at 16.7% for Q4 2025, down from 40.05% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 40.05% in Q3 2025 to a low of 189.15% in Q2 2023.
  • Median EBITDA Margin over the past 3 years was 6.1% (2024), compared with a mean of 25.18%.
  • The largest YoY upside for EBITDA Margin was 17895bps in 2024 against a maximum downside of -4536bps in 2024.
  • Over 3 years, EBITDA Margin stood at 29.49% in 2023, then tumbled by -50bps to 14.68% in 2024, then rose by 14bps to 16.7% in 2025.
  • Per Business Quant, the three most recent readings for ALAB's EBITDA Margin are 16.7% (Q4 2025), 40.05% (Q3 2025), and 27.13% (Q2 2025).